Literature DB >> 24763686

Increased genomic integrity of an improved protein-based mouse induced pluripotent stem cell method compared with current viral-induced strategies.

Hansoo Park1, Dohoon Kim, Chun-Hyung Kim, Ryan E Mills, Mi-Yoon Chang, Rebecca Cheryl Iskow, Sanghyeok Ko, Jung-Il Moon, Hyun Woo Choi, Paulo Sng Man Yoo, Jeong Tae Do, Min-Joon Han, Eun Gyo Lee, Joon Ki Jung, Chengsheng Zhang, Robert Lanza, Kwang-Soo Kim.   

Abstract

It has recently been shown that genomic integrity (with respect to copy number variants [CNVs]) is compromised in human induced pluripotent stem cells (iPSCs) generated by viral-based ectopic expression of specific transcription factors (e.g., Oct4, Sox2, Klf4, and c-Myc). However, it is unclear how different methods for iPSC generation compare with one another with respect to CNV formation. Because array-based methods remain the gold standard for detecting unbalanced structural variants (i.e., CNVs), we have used this approach to comprehensively identify CNVs in iPSC as a proxy for determining whether our modified protein-based method minimizes genomic instability compared with retro- and lentiviral methods. In this study, we established an improved method for protein reprogramming by using partially purified reprogramming proteins, resulting in more efficient generation of iPSCs from C57/BL6J mouse hepatocytes than using protein extracts. We also developed a robust and unbiased 1 M custom array CGH platform to identify novel CNVs and previously described hot spots for CNV formation, allowing us to detect CNVs down to the size of 1.9 kb. The genomic integrity of these protein-based mouse iPSCs (p-miPSCs) was compared with miPSCs developed from viral-based strategies (i.e., retroviral: retro-miPSCs or lentiviral: lenti-miPSCs). We identified an increased CNV content in lenti-miPSCs and retro-miPSCs (29∼53 CNVs) compared with p-miPSCs (9∼10 CNVs), indicating that our improved protein-based reprogramming method maintains genomic integrity better than current viral reprogramming methods. Thus, our study, for the first time to our knowledge, demonstrates that reprogramming methods significantly influence the genomic integrity of resulting iPSCs.

Entities:  

Keywords:  Copy number variant; Genomic integrity; Induced pluripotent stem cell; Protein-based iPSC; Reprogramming method

Mesh:

Substances:

Year:  2014        PMID: 24763686      PMCID: PMC4006484          DOI: 10.5966/sctm.2013-0149

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  33 in total

1.  Efficient calculation of interval scores for DNA copy number data analysis.

Authors:  Doron Lipson; Yonatan Aumann; Amir Ben-Dor; Nathan Linial; Zohar Yakhini
Journal:  J Comput Biol       Date:  2006-03       Impact factor: 1.479

2.  Copy number variation and selection during reprogramming to pluripotency.

Authors:  Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

3.  Recurrent copy number variations in human induced pluripotent stem cells.

Authors:  Kristen Martins-Taylor; Benjamin S Nisler; Seth M Taapken; Tiwanna Compton; Leann Crandall; Karen Dyer Montgomery; Marc Lalande; Ren-He Xu
Journal:  Nat Biotechnol       Date:  2011-06-07       Impact factor: 54.908

4.  Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression.

Authors:  Linzhao Cheng; Nancy F Hansen; Ling Zhao; Yutao Du; Chunlin Zou; Frank X Donovan; Bin-Kuan Chou; Guangyu Zhou; Shijie Li; Sarah N Dowey; Zhaohui Ye; Settara C Chandrasekharappa; Huanming Yang; James C Mullikin; P Paul Liu
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

5.  Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.

Authors:  Aaron R Quinlan; Michael J Boland; Mitchell L Leibowitz; Svetlana Shumilina; Sidney M Pehrson; Kristin K Baldwin; Ira M Hall
Journal:  Cell Stem Cell       Date:  2011-10-04       Impact factor: 24.633

6.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

7.  Significant gene content variation characterizes the genomes of inbred mouse strains.

Authors:  Gene Cutler; Lisa A Marshall; Ni Chin; Helene Baribault; Paul D Kassner
Journal:  Genome Res       Date:  2007-11-07       Impact factor: 9.043

8.  A highly annotated whole-genome sequence of a Korean individual.

Authors:  Jong-Il Kim; Young Seok Ju; Hansoo Park; Sheehyun Kim; Seonwook Lee; Jae-Hyuk Yi; Joann Mudge; Neil A Miller; Dongwan Hong; Callum J Bell; Hye-Sun Kim; In-Soon Chung; Woo-Chung Lee; Ji-Sun Lee; Seung-Hyun Seo; Ji-Young Yun; Hyun Nyun Woo; Heewook Lee; Dongwhan Suh; Seungbok Lee; Hyun-Jin Kim; Maryam Yavartanoo; Minhye Kwak; Ying Zheng; Mi Kyeong Lee; Hyunjun Park; Jeong Yeon Kim; Omer Gokcumen; Ryan E Mills; Alexander Wait Zaranek; Joseph Thakuria; Xiaodi Wu; Ryan W Kim; Jim J Huntley; Shujun Luo; Gary P Schroth; Thomas D Wu; HyeRan Kim; Kap-Seok Yang; Woong-Yang Park; Hyungtae Kim; George M Church; Charles Lee; Stephen F Kingsmore; Jeong-Sun Seo
Journal:  Nature       Date:  2009-07-08       Impact factor: 49.962

9.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

10.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more
  7 in total

Review 1.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

2.  Generation of murine induced pluripotent stem cells by using high-density distributed electrodes network.

Authors:  Ming-Yu Lu; Zhihong Li; Shiaw-Min Hwang; B Linju Yen; Gwo-Bin Lee
Journal:  Biomicrofluidics       Date:  2015-09-11       Impact factor: 2.800

Review 3.  Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications.

Authors:  Clara Steichen; Zara Hannoun; Eléanor Luce; Thierry Hauet; Anne Dubart-Kupperschmitt
Journal:  World J Stem Cells       Date:  2019-10-26       Impact factor: 5.326

Review 4.  Stem cells: the pursuit of genomic stability.

Authors:  Saranya P Wyles; Emma B Brandt; Timothy J Nelson
Journal:  Int J Mol Sci       Date:  2014-11-14       Impact factor: 5.923

5.  p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming.

Authors:  Lu Gong; Xiao Pan; Haide Chen; Lingjun Rao; Yelin Zeng; Honghui Hang; Jinrong Peng; Lei Xiao; Jun Chen
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

Review 6.  Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering.

Authors:  Zohreh Sadat Badieyan; Todd Evans
Journal:  Stem Cells Transl Med       Date:  2019-03-19       Impact factor: 6.940

Review 7.  Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process.

Authors:  Valentina Turinetto; Luca Orlando; Claudia Giachino
Journal:  Int J Mol Sci       Date:  2017-09-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.